国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2014年
18期
2459-2461
,共3页
顾金花%顾涛%周丽娜%王李强%陈玲
顧金花%顧濤%週麗娜%王李彊%陳玲
고금화%고도%주려나%왕리강%진령
胃癌%血清%肿瘤指标%化疗
胃癌%血清%腫瘤指標%化療
위암%혈청%종류지표%화료
gastric cancer%serum%tumor marker%chemotherapy
目的:探讨检测晚期胃癌患者血清血管内皮生长因子(VEGF)、癌胚抗原(CEA)、糖类抗原19-9(CA19-9)和铁蛋白(SF)水平变化在化疗疗效评估中的价值。方法测定85例晚期胃癌患者化疗前、化疗1周期后血清VEGF、CEA、CA19-9和SF的水平;并在化疗2周期后进行疗效评价。结果化疗有效组血清VEGF、CEA、CA19-9和SF水平均较化疗前明显下降(P<0.05);进展组血清VEGF、CEA水平均较化疗前明显上升(P<0.05);稳定组血清VEGF、CEA、CA19-9、SF及进展组血清CA19-9、SF水平均较治疗前无明显变化(P>0.05);多重回归分析显示,血清CEA、VEGF、CA19-9水平变化与化疗疗效相关,具有统计学意义,而血清SF与化疗疗效相关性无统计学意义(t=1.58,P=0.119)。结论血清CEA、VEGF、CA19-9水平变化与胃癌化疗疗效相关,其检测有助于预测化疗效果。
目的:探討檢測晚期胃癌患者血清血管內皮生長因子(VEGF)、癌胚抗原(CEA)、糖類抗原19-9(CA19-9)和鐵蛋白(SF)水平變化在化療療效評估中的價值。方法測定85例晚期胃癌患者化療前、化療1週期後血清VEGF、CEA、CA19-9和SF的水平;併在化療2週期後進行療效評價。結果化療有效組血清VEGF、CEA、CA19-9和SF水平均較化療前明顯下降(P<0.05);進展組血清VEGF、CEA水平均較化療前明顯上升(P<0.05);穩定組血清VEGF、CEA、CA19-9、SF及進展組血清CA19-9、SF水平均較治療前無明顯變化(P>0.05);多重迴歸分析顯示,血清CEA、VEGF、CA19-9水平變化與化療療效相關,具有統計學意義,而血清SF與化療療效相關性無統計學意義(t=1.58,P=0.119)。結論血清CEA、VEGF、CA19-9水平變化與胃癌化療療效相關,其檢測有助于預測化療效果。
목적:탐토검측만기위암환자혈청혈관내피생장인자(VEGF)、암배항원(CEA)、당류항원19-9(CA19-9)화철단백(SF)수평변화재화료료효평고중적개치。방법측정85례만기위암환자화료전、화료1주기후혈청VEGF、CEA、CA19-9화SF적수평;병재화료2주기후진행료효평개。결과화료유효조혈청VEGF、CEA、CA19-9화SF수평균교화료전명현하강(P<0.05);진전조혈청VEGF、CEA수평균교화료전명현상승(P<0.05);은정조혈청VEGF、CEA、CA19-9、SF급진전조혈청CA19-9、SF수평균교치료전무명현변화(P>0.05);다중회귀분석현시,혈청CEA、VEGF、CA19-9수평변화여화료료효상관,구유통계학의의,이혈청SF여화료료효상관성무통계학의의(t=1.58,P=0.119)。결론혈청CEA、VEGF、CA19-9수평변화여위암화료료효상관,기검측유조우예측화료효과。
Objective To investigate the values of serum vascular endothelial growth factor (VEGF) ,carcinoembryonic antigen (CEA) ,carbohydrate antigen 19-9 (CA19-9) and ferritin (SF) determination in assessing the efficacy of chemotherapy in patients with advanced gastric cancer .Methods Wedetermined the concentrations of serum VEGF ,CEA ,CA19-9 and SF for 85 patients with advanced gastric cancer ,before and after 1 cycles of chemotherapy and evaluated the the effect of chemotherapy after 2 cycle of chemotherapy .Results In effective group ,serum concentrations of VEGF ,CEA ,CA19-9 and SF significantly decreased after chem-otherapy cycle(P< 0 .05) ,serum VEGF and CEA concentrations significantly increased in progress group (P< 0 .05) ,serum VEGF ,CEA ,CA19-9 and SF concentrations in stable group and serum CA19-9 and SF concentrations in progress group did not change significantly(P> 0 .05) ,compared with those before chemotherapy cycle .Multiple regression analysis showed that serum CEA ,VEGF ,CA19-9 concentration changes correlated with chemotherapy efficiency ,while serum SF didn′t(t=1 .58 ,P=0 .119) . Conclusion Serum CEA ,VEGF ,CA19-9 concentration changes associated with gastric cancer chemotherapy efficiency ,which help predict the efficiency of chemotherapy .